BAXTER'S $448 MIL. SALE OF DIAGNOSTICS MANUFACTURING BUSINESSES
This article was originally published in The Gray Sheet
Executive Summary
BAXTER'S $448 MIL. SALE OF DIAGNOSTICS MANUFACTURING BUSINESSES will help the company reduce its debt-to-capital ratio to about 40% by the end of 1994, according to Baxter. The company announced Oct. 3 a definitive agreement for the sale of its manufacturing operations to Bain Capital, expected to close before the end of the year. Baxter is retaining exclusive U.S. distribution fights to its diagnostics products businesses for five years.